These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16256085)

  • 21. Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding.
    Currie PJ; Coscina DV
    Neuroreport; 1997 Dec; 8(17):3759-62. PubMed ID: 9427365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of intraduodenally administered enterostatin in rats: inhibition of food.
    Mei J; Erlanson-Albertsson C
    Obes Res; 1996 Mar; 4(2):161-5. PubMed ID: 8681049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of enterostatin (Val-Pro-Asp-Pro-Arg) on fat intake and blood levels of glucose and insulin in rats.
    Koizumi M; Sato H; Seguro K; Ide H; Morinaga Y; Kimura S
    Methods Find Exp Clin Pharmacol; 2001 Jun; 23(5):235-9. PubMed ID: 11712642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT(2A/2C) receptor antagonists in the paraventricular nucleus attenuate the action of DOI on NPY-stimulated eating.
    Currie PJ; Saxena N; Tu AY
    Neuroreport; 1999 Sep; 10(14):3033-6. PubMed ID: 10549818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice.
    Somerville EM; Horwood JM; Lee MD; Kennett GA; Clifton PG
    Eur J Neurosci; 2007 May; 25(10):3115-24. PubMed ID: 17561825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y.
    Grignaschi G; Sironi F; Samanin R
    Eur J Pharmacol; 1995 Feb; 274(1-3):221-4. PubMed ID: 7768274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice.
    Lee MD; Somerville EM; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2004 Oct; 176(1):39-49. PubMed ID: 15138762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enterostatin increases extracellular serotonin and dopamine in the lateral hypothalamic area in rats measured by in vivo microdialysis.
    Koizumi M; Kimura S
    Neurosci Lett; 2002 Mar; 320(1-2):96-8. PubMed ID: 11849772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic paraventricular 5-hydroxytryptamine inhibits the effects of ghrelin on eating and energy substrate utilization.
    Currie PJ; John CS; Nicholson ML; Chapman CD; Loera KE
    Pharmacol Biochem Behav; 2010 Nov; 97(1):152-5. PubMed ID: 20573591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat.
    Giraudo SQ; Billington CJ; Levine AS
    Brain Res; 1998 Jan; 782(1-2):18-23. PubMed ID: 9519245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enterostatin--a peptide regulating fat intake.
    Erlanson-Albertsson C; York D
    Obes Res; 1997 Jul; 5(4):360-72. PubMed ID: 9285845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CB1 receptors in the paraventricular nucleus of the hypothalamus modulate the release of 5-HT and GABA to stimulate food intake in rats.
    Cruz-Martínez AM; Tejas-Juárez JG; Mancilla-Díaz JM; Florán-Garduño B; López-Alonso VE; Escartín-Pérez RE
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1247-1259. PubMed ID: 30217553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enterostatin and its target mechanisms during regulation of fat intake.
    Berger K; Winzell MS; Mei J; Erlanson-Albertsson C
    Physiol Behav; 2004 Dec; 83(4):623-30. PubMed ID: 15621068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medial hypothalamic serotonin: effects on deprivation and norepinephrine-induced eating.
    Weiss GF; Papadakos P; Knudson K; Leibowitz SF
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1223-30. PubMed ID: 3027720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic ICV enterostatin preferentially reduced fat intake and lowered body weight.
    Lin L; Chen J; York DA
    Peptides; 1997; 18(5):657-61. PubMed ID: 9213358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The peptide enterostatin may produce early satiety.
    Lin L; McClanahan S; York DA; Bray GA
    Physiol Behav; 1993 Apr; 53(4):789-94. PubMed ID: 8511187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake.
    Erlanson-Albertsson C; Mei J; Okada S; York D; Bray GA
    Physiol Behav; 1991 Jun; 49(6):1191-4. PubMed ID: 1896501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptides that regulate food intake: effect of peptide histidine isoleucine on consummatory behavior in rats.
    Olszewski PK; Wirth MM; Shaw TJ; Grace MK; Levine AS
    Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1445-53. PubMed ID: 12595279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic effects of intracerebral ventricular enterostatin in Osborne-Mendel rats fed a high-fat diet.
    Okada S; Lin L; York DA; Bray GA
    Physiol Behav; 1993 Aug; 54(2):325-9. PubMed ID: 8372128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of central enterostatin on fat intake in neonatal chicks.
    Jonaidi H; Rasooli R
    Neurosci Lett; 2013 Jan; 533():60-4. PubMed ID: 23178475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.